`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`AT CLARKSBURG
`
`REGENERON PHARMACEUTICALS, INC.,
`
`Plaintiff,
`
`v.
`
`MYLAN PHARMACEUTICALS INC.,
`
`Defendant.
`
`Case No. 1:22-cv-00061-TSK
`
`MYLAN PHARMACEUTICAL INC.’S POST-HEARING SUPPLEMENT
`
`Mylan submits herewith an update to its proposed schedules which were previously
`
`submitted as an exhibit to the Parties’ Rule 26(f) Report (Dkt. No. 75-2). Regeneron’s October
`
`19, 2022 filing reveals (again) the unworkability of its unrealistic schedule, and illustrates the
`
`problems with Regeneron’s demands to indiscriminately apply 35 U.S.C. § 271(e)(4)(D) without
`
`considering limiting factors—especially when there are other available mechanisms for injunctive
`
`relief (as set forth in Mylan’s prior submissions (Dkt. Nos. 26, 75)).
`
`Respectfully submitted,
`
`STEPTOE & JOHNSON PLLC
`
`/s/ William J. O’Brien
`Gordon H. Copland (WVSB #828)
`William J. O’Brien (WVSB #10549)
`400 White Oaks Boulevard
`Bridgeport, WV 26330
`(304) 933-8162
`gordon.copland@steptoe-johnson.com
`william.obrien@steptoe-johnson.com
`
`
`
`Case 1:22-cv-00061-TSK-JPM Document 85 Filed 10/20/22 Page 2 of 3 PageID #: 2203
`
`Of Counsel (admitted pro hac vice):
`William A. Rakoczy
`Heinz J. Salmen
`Eric R. Hunt
`Neil B. McLaughlin
`Lauren M. Lesko
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 W. Hubbard St., Suite 500
`Chicago, IL 60654
`(312) 527-2157
`wrakoczy@rmmslegal.com
`hsalmen@rmmslegal.com
`ehunt@rmmslegal.com
`nmclaughlin@rmmslegal.com
`llesko@rmmslegal.com
`
`Counsel for Defendant Mylan Pharmaceuticals Inc.
`
`2
`
`
`
`Case 1:22-cv-00061-TSK-JPM Document 85 Filed 10/20/22 Page 3 of 3 PageID #: 2204
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on the 20th day of October 2022, I filed the foregoing “Mylan
`
`Pharmaceuticals Inc.’s Post-Hearing Supplement” using the Court’s CM/ECF system, which will
`
`send notification of the same to the following counsel of record for Plaintiff:
`
`David R. Pogue (drpogue@cdkrlaw.com)
`Steven Robert Ruby (sruby@cdkrlaw.com)
`CAREY, DOUGLAS, KESSLER & RUBY, PLLC
`707 Virginia Street East
`901 Chase Tower (25301)
`P.O. Box 913
`Charleston, West Virginia 25323
`(304) 345-1234
`
`David I. Berl (dberl@wc.com)
`Ellen E. Oberwetter (eoberwetter@wc.com)
`Thomas S. Fletcher (tfletcher@wc.com)
`Teagan J. Gregory (tgregory@wc.com)
`Nicholas Jordan (njordan@wc.com)
`Kathryn S. Kayali (kkayali@wc.com)
`Arthur J. Argall III (aargall@wc.com)
`Shaun P. Mahaffy (smahaffy@wc.com)
`Adam Pan (apan@wc.com)
`Andrew V. Trask (atrask@wc.com)
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue, SW
`Washington, DC 20024
`(202) 434-5000
`
`Attorneys for Plaintiff Regeneron Pharmaceuticals, Inc.
`
`/s/ William J. O’Brien
`Gordon H. Copland (WVSB #828)
`William J. O’Brien (WVSB #10549)
`STEPTOE & JOHNSON PLLC
`400 White Oaks Boulevard
`Bridgeport, WV 26330
`(304) 933-8162
`gordon.copland@steptoe-johnson.com
`william.obrien@steptoe-johnson.com
`
`Attorneys for Defendant Mylan Pharmaceuticals Inc.
`
`3
`
`